Patent Ductus Arteriosus: Clinical Trials

9 trials for Patent Ductus Arteriosus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 terminated, 1 active not recruiting, 1 unknown. 9 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 5, Terminated 2, Active not recruiting 1, Unknown 1
Phase 22Terminated 1, Unknown 1

Follow Patent Ductus Arteriosus: new trials by email Literature Review of Patent Ductus Arteriosus trials Research Report on Patent Ductus Arteriosus

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PAIR (Paracetamol and Ibuprofen Research) Pilot Trial
Paracetamol injection, Ibuprofen injection - Patent Ductus Arteriosus
Phase 2 / Phase 3UnknownManchester University NHS Foundation Trust322021-09-032023-10-30
Management of the PDA Trial
Active Treatment, Expectant Management - Infant, Premature, Patent Ductus Arteriosus
Phase 3Active not recruitingNICHD Neonatal Research Network4822019-02-222026-05-12
Acetaminophen vs Indomethacin in Treating hsPDA
Indomethacin, Acetaminophen - Patent Ductus Arteriosus
Phase 3TerminatedUniversity of Tennessee372016-06-012019-12-03
Platelet Transfusion for Treatment of Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates
Liberal platelet transfusion, Restrictive platelet transfusion, Paracetamol - Patent Ductus Arteriosus
Phase 3CompletedPost Graduate Institute of Medical Education and Research, Chandigarh442016-03-012018-04-06
Early Ibuprofen Treatment of Patent Ductus Arteriosus (PDA) in Premature Infants (TRIOCAPI)
Ibuprofen, Placebo - Patent Ductus Arteriosus
Phase 3CompletedNantes University Hospital3632012-03-012026-09-14
Echocardiographically Guided Versus Standard Ibuprofen Treatment for Patent Ductus Arteriosus
Ibuprofen EchoG, Standard ibuprofen treatment - Patent Ductus Arteriosus
Phase 3CompletedFundacion para la Investigacion Biomedica del Hospital Universitario la Paz492009-05-012012-05-08
An Escalating Dose Indomethacin for the Treatment of Persistent Patent Ductus Arteriosus (PDA) In Preterm Infants
Indomethacin - Patent Ductus Arteriosus
Phase 2 / Phase 3TerminatedUniversity of Calgary92008-08-012016-08-18
Safety and Efficacy Study of Ibuprofen l-Lysine Solution in Premature Infants for Treatment of PDA
ibuprofen l-lysine iv solution (NeoProfen (R) ) - Patent Ductus Arteriosus
Phase 3CompletedFarmacon2002-12-012007-02-27
Ibuprofen vs. Continuous Indomethacin in the Treatment of PDA
Continuous indomethacin, ibuprofen - Patent Ductus Arteriosus
Phase 3CompletedShaare Zedek Medical Center702002-02-012011-07-21

Narrower conditions

Ductus Arteriosus, Patent (9)  ·  Premature Birth (2)  ·  Infant, Newborn, Diseases (1)

Broader conditions

Cardiovascular Abnormalities (9)  ·  Cardiovascular Diseases (9)  ·  Congenital Abnormalities (9)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9)  ·  Heart Defects, Congenital (9)  ·  Heart Diseases (9)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Obstetric Labor Complications (2)  ·  Obstetric Labor, Premature (2)  ·  Pregnancy Complications (2)  ·  Urogenital Diseases (2)

Interventions

Ibuprofen (5)  ·  Acetaminophen (3)  ·  Indomethacin (2)  ·  Watchful Waiting (1)  ·  crocin (1)

Sponsors

Farmacon (1)  ·  Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz (1)  ·  Manchester University NHS Foundation Trust (1)  ·  NICHD Neonatal Research Network (1)  ·  Nantes University Hospital (1)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (1)  ·  Shaare Zedek Medical Center (1)  ·  University of Calgary (1)  ·  University of Tennessee (1)

Countries

United States (2)  ·  Canada (1)  ·  France (1)  ·  India (1)  ·  Israel (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Adelina Pellicer, PhDMD (1)  ·  Amuchou S Soraisham, MD, DM (1)  ·  Arin Mukherjee, MRCPCH (1)  ·  Cathy Hammerman, MD (1)  ·  Jacob V Aranda, MD, PhD (1)  ·  Joan Riera, Bio-Engineer (1)  ·  Sourabh Dutta, MD (1)

Results publications

PMID 18628265, PMID 21094951, PMID 22065264, PMID 23258386, PMID 24223740, PMID 24854626, PMID 25653299, PMID 26168357, PMID 26244949, PMID 26283668, PMID 26672023, PMID 30940676, PMID 33301630, PMID 33307111, PMID 41364689, PMID 41550606, PMID 4418268, PMID 6338474, PMID 6343572

NIH funding

UG1HD112079 (1), UG1HD112097 (1), UG1HD112100 (1)